Adoptive cell therapy for sarcoma

about

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities Current status of engineered T-cell therapy for synovial sarcoma.Genetically Modified T-cell Therapy for the Treatment of Osteosarcoma: An Update.Current status of immunotherapy for sarcomas.

P2860

Q28074619-FB9DED7C-1405-4BE3-B3BD-411CB5B2F755 Q38916522-E01F7156-3929-48C0-8C6B-040704E92156 Q42576424-54DDA7C3-8C0F-4ACC-A59A-4CC7CF1B79DD Q49557938-1BA9DFE2-5E38-4C9B-B537-B5CB3FE9B50F

P2860

Adoptive cell therapy for sarcoma

Item

http://www.wikidata.org/entity/Q27009541

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Adoptive cell therapy for sarcoma

@ast

Adoptive cell therapy for sarcoma

@en

Adoptive cell therapy for sarcoma

@nl

type

Item

label

Adoptive cell therapy for sarcoma

@ast

Adoptive cell therapy for sarcoma

@en

Adoptive cell therapy for sarcoma

@nl

prefLabel

Adoptive cell therapy for sarcoma

@ast

Adoptive cell therapy for sarcoma

@en

Adoptive cell therapy for sarcoma

@nl

P1476

Adoptive cell therapy for sarcoma

@en

P2093

Melinda Mata

http://www.w3.org/2001/XMLSchema#string

Stephen Gottschalk

http://www.w3.org/2001/XMLSchema#string

P2860

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Adoptive immunotherapy for cancer: building on success

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Cancer regression in patients after transfer of genetically engineered lymphocytes

Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma

Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook

P304

21-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3528011

http://www.w3.org/2001/XMLSchema#string

P356

10.2217/IMT.14.98

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25572477

http://www.w3.org/2001/XMLSchema#string

P932

4331182

http://www.w3.org/2001/XMLSchema#string

Adoptive cell therapy for sarcoma

about

P2860

P2860

Adoptive cell therapy for sarcoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P577

P698

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P577

P698

P932